Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

American Family Physician March 15, 2005 Paul T. Giboney	Mildly Elevated Liver Transaminase Levels in the Asymptomatic Patient Mild elevations in liver chemistry tests can reveal serious underlying conditions or have transient and benign etiologies. If elevations persist after an appropriate period of observation, further testing may include ultrasonography and other serum studies.
American Family Physician September 1, 2006 Heidelbaugh & Bruderly	Cirrhosis and Chronic Liver Failure: Part I. Diagnosis and Evaluation Part I of a two-part on how to diagnose and determine treatment for cirrhosis and chronic liver failure.
HHMI Bulletin Fall 2012 Sarah C. P. Williams	The Fat You Can't See Without the liver acting as a filter and energy producer, a person can't survive, and no artificial organ can perform all of its duties. But in one in three Americans -- and similar numbers in other developed nations -- the liver has lost its luster.
American Family Physician November 1, 2001 Thomas R. Riley	Preventive Strategies in Chronic Liver Disease Chronic liver disease is the 10th leading cause of death in the United States. Preventive care can significantly reduce the progression of liver disease. Part I: Alcohol, Vaccines, Toxic Medications and Supplements, Diet and Exercise...
American Family Physician January 15, 2004 Roche & Kobos	Jaundice in the Adult Patient Jaundice in an adult patient can be caused by a wide variety of benign or life-threatening disorders. Organizing the differential diagnosis by prehepatic, intrahepatic, and posthepatic causes may help make the work-up more manageable.
Nursing December 2008 Susan Simmons Holcomb	Caring for a patient with chronic hepatitis C Teach your patient about improved treatments that can help him deal with this potentially deadly infection.
American Family Physician March 15, 2004	Management of Hepatitis C: Evaluating Suitability for Drug Therapy Chronic hepatitis C virus infection is a common and serious disease. Although an estimated 2.7 million persons in the United States have this disease, most have not yet been diagnosed.
Nurse Practitioner December 2009 Gujral & Collantes	Understanding Viral Hepatitis: A guide for primary care Recent advancements in the field of genomics and proteomics technology have given researchers and clinicians more insight on disease pathogenesis and helped create more tailored approaches to the treatment of these conditions.
Nursing October 2011 Habib & Saunders	The yellow bird of jaundice: Recognizing biliary obstruction This article describes the various possible causes of biliary obstruction, diagnostic studies and treatment options, and nursing considerations for patients with this disorder.
Nurse Practitioner July 2010 Kristine A. Scordo	Treating antiretroviral-induced dyslipidemia in HIV-infected adults Studies indicate that HIV-infected patients (both males and females) may be at an increased risk for the development of cardiovascular disease
Nursing Management January 2012 Lawrence et al.	Type 2 Diabetes: Growing to Epic Proportions Affecting all age groups and all aspects of a person's life, diabetes is a major public health issue worldwide, requiring lifelong behavioral and lifestyle changes and support.
American Family Physician June 15, 2004 Darwin Deen	Metabolic Syndrome: Time for Action Family physicians can be more effective in helping patients to change their lifestyle behaviors by assessing each patient for the presence of specific risk factors, clearly communicating these risk factors to patients, identifying appropriate interventions to address specific risks, and assisting patients in identifying barriers to behavior change.
Nurse Practitioner December 2011	Managing pain in obese patients Obesity-related pain conditions can limit the patient's efforts at increasing activity and limit quality of life. This article will offer information on these conditions and treatment options.
Nurse Practitioner September 2011 Cheryl L. Gainer	Celiac Disease: Helping Patients Live Gluten-Free A review of the screening, diagnosis, and treatment of celiac disease.
Nursing September 2010 Margaret M. Bolton	Sounding the alarm about metabolic syndrome Any health problem that affects a third of American adults is sure to impact your nursing practice. Metabolic syndrome, a growing and commonly silent condition, poses a significant public health crisis.
Nursing July 2011 Susan Simmons	Recognizing and Managing Rheumatoid Arthritis Here's what rheumatoid arthritis is, how it's diagnosed and treated, and what you can do to help patients manage the disease.
HHMI Bulletin Aug 2010 Marc Wortman	When Lean Isn't Good Enough Even someone slim may be hiding signs of type 2 diabetes.
American Journal of Nursing February 2010 Melissa M. Smith	Emergency: Variceal Hemorrhage from Esophageal Varices Associated with Alcoholic Liver Disease This article describes alcoholic cirrhosis and its complications, discusses the etiology of esophageal varices and the risk factors for hemorrhage, and addresses emergent treatment.
American Family Physician October 1, 2005 Francine Rainone	Milk Thistle Milk thistle has been used as a cytoprotectant for the treatment of liver disease, for the treatment and prevention of cancer, and as a supportive treatment of Amanita phalloides poisoning. Clinical studies are largely heterogeneous and contradictory.
Nursing Management March 2012 Yvonne D'Arcy	Pain and obesity It can be a challenge to provide effective pain management for obese patients; however, a multimodal pain management regimen that combines medications and complementary techniques can help increase pain relief.
American Family Physician June 1, 2006	Nonalcoholic Fatty Liver Disease: What You Should Know A patient guide: What is nonalcoholic fatty liver disease (NAFLD)?... How can my doctor tell if I have NAFLD?... What can I expect?... etc.
American Family Physician November 15, 2001 Thomas R. Riley	Preventive Strategies in Chronic Liver Disease: Part II. Cirrhosis Cirrhosis is a diffuse process characterized by fibrosis and the conversion of normal liver architecture into structurally abnormal nodules. Strategies have been established to prevent complications in patients with cirrhosis...
Nurse Practitioner November 2011 Tracy Brazziel et al.	Stopping the Wave of PAD Early detection and diagnosis of atherosclerotic disease is imperative. Here, learn the risk factors, screening and diagnosis for this disease.
The Motley Fool November 18, 2009 Brian Orelli	Drug Lowers Cholesterol; Stock Follows ISIS has a hard time at American Heart Association despite good efficacy data.
American Family Physician June 15, 2006 Brundage & Fitzpatrick	Hepatitis A The introduction of hepatitis A vaccines in 1995 led to a drop in the number of reported cases of hepatitis A and a shift to a higher percentage of cases occurring in older age groups. The hepatitis A virus survives for extended periods in the environment.
Nurse Practitioner February 2011 Jennifer M. Belavic	Annual Drug Update: 2010 in Review In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available.
Nursing October 2011 Elizabeth Heavey	Obesity in pregnancy: Deliver sensitive care This article addresses the health risks of obesity to mother and baby during pregnancy, labor, and delivery and discusses what you can do to mitigate those risks.
Nurse Practitioner July 2008 Lynn A. Kelso	Cirrhosis: Caring for Patients with End-stage Liver Failure Caring for patients with end-stage liver disease can be very challenging for NPs.
American Family Physician September 1, 2006 Heidelbaugh & Sherbondy	Cirrhosis and Chronic Liver Failure: Part II. Complications and Treatment Part II of a two-part article on treatments that can help alleviate complications due to cirrhosis and chronic liver failure.
Nursing June 2010 Daniel A. Hussar	New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs.
Science News June 9, 2007 Janet Raloff	Super-Size Mice--Fast Food Hurts Rodents When rodents eat the equivalent of a fast-food diet, they develop health problems similar to those seen in the movie Super Size Me.
Nursing February 2010 Daniel A. Hussar	New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs.
Nursing June 2011 Daniel A. Hussar	New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis.
American Family Physician October 1, 2000 Kelly W. Jones, Pharm.D. & Supen R. Patel, M.D.	A Family Physician's Guide to Monitoring Methotrexate Although the drug is usually prescribed by a subspecialist, a family physician may assume responsibility for monitoring methotrexate therapy...
Nursing March 2009 Mary G. McKinley	Recognizing and Responding to Acute Liver Failure By quickly recognizing the signs and symptoms of acute liver failure, you can help your patient improve his odds of surviving this often-deadly condition.
Nursing March 2012 Daniel A. Hussar	New Drugs 2012: part I In this article, you'll learn about 11 recently approved drugs.
The Motley Fool February 11, 2010 Brian Orelli	A Wonder Drug With Not-So-Wonderful Side Effects Wonder drug or not, Isis Pharmaceuticals and Genzyme's cholesterol drug mipomersen's sales will be limited by side effects.
Nurse Practitioner February 2012 Jennifer M. Belavic	Annual drug update 2011 in review Many new medications were approved throughout 2011. This article will cover a variety of drugs that will be useful in nurse practitioner practice
Chemistry World September 11, 2013 Emma Stoye	Call to overhaul liver toxicity testing Outdated assays for monitoring liver health could have caused dozens of drug candidates to be wrongly scrapped during development, according to new research.
The Motley Fool August 10, 2010 Ryan McBride	Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive.
American Family Physician September 1, 2006	Cirrhosis and Chronic Liver Failure: What You Should Know The basics about cirrhosis and chronic liver failure.
AskMen.com Alex Santoso	Liver Health: The Beer Drinker's Best Herbs Studies have suggested that, when consumed in moderation, beer has many health benefits.
AskMen.com Jacob Franek	Preventable Diseases Each and every year, millions of men die as a result of diseases that are, for the most part, entirely preventable.
The Motley Fool August 5, 2010 Brian Orelli	Blockbuster Efficacy! Not-So-Blockbuster Safety! Isis and Genzyme's wonder drug has not-so-wonderful side effects. Still.
Chemistry World December 2006 Dennis Rouvray	Fat of the Land As we become progressively more rotund, our body chemistry undergoes critical changes that have a major impact on our health.
Science News October 6, 2007 Janet Raloff	Food for Thought: Diminishing Obesity's Risks Mouse data suggest that, properly managed, obesity can be benign.
American Family Physician November 15, 2006 Mark H. Ebell	Point-of-Care Guides The Model for End-Stage Liver Disease (MELD), United Network for Organ Sharing modification.
American Family Physician July 1, 2004 Maggie B. Covington	Omega-3 Fatty Acids Over the past 20 years, there has been a dramatic increase in the scientific scrutiny of and public interest in omega-3 and omega-6 fatty acids and their impact on personal health.
Science News January 21, 2006 Janet Raloff	Caffeinated Liver Defense A 20-year long study recently concluded people who routinely drank more than two cups of coffee or tea per day faced only half the risk of being hospitalized with cirrhosis and other types of serious liver disease as did people consuming less of these drinks.
The Motley Fool September 2, 2011 Brian Orelli	Delcath Wants a Do-Over You'd think a drug failing to show an effect would be the worst thing that could happen to a biotech investor, but mixed results are actually much worse.